No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease

Background: Autosomal dominant polycystic kidney disease (ADPKD) shows a variable clinical course suggesting that genetic modifiers might play a role. There are conflicting results about the effect of angiotensin-converting enzyme (ACE) gene polymorphism on the progression of renal failure in ADPKD....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of nephrology 2003-11, Vol.23 (6), p.466-470
Hauptverfasser: Ecder, Tevfik, McFann, Kimberly K., Raynolds, Mary V., Schrier, Robert W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 470
container_issue 6
container_start_page 466
container_title American journal of nephrology
container_volume 23
creator Ecder, Tevfik
McFann, Kimberly K.
Raynolds, Mary V.
Schrier, Robert W.
description Background: Autosomal dominant polycystic kidney disease (ADPKD) shows a variable clinical course suggesting that genetic modifiers might play a role. There are conflicting results about the effect of angiotensin-converting enzyme (ACE) gene polymorphism on the progression of renal failure in ADPKD. Also, the association between ACE gene polymorphism and the occurrence of left ventricular hypertrophy (LVH) has not been investigated in patients with ADPKD. Methods: ACE genotype analysis was performed in 409 Caucasian patients (137 male, 272 female) with ADPKD. Echocardiographic examination was done in 164 of these patients. Results: There were no significant differences between different ACE genotypes regarding renal function, renal volume, urinary protein excretion, blood pressure, the rate of hypertension, the age at diagnosis of hypertension, the rate of LVH and the incidence of end-stage renal disease (ESRD). Conclusion: ACE gene polymorphism does not have a significant effect on the development of ESRD and the prevalence of LVH in patients with ADPKD.
doi_str_mv 10.1159/000074653
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_14600431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>453405541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-7db3988ced99d9e56dda3faf7d155c8e810a6e86260daabc3f01027f0c9c5fac3</originalsourceid><addsrcrecordid>eNqF0UGL1DAUB_AiijuuHjwLEgQFD9WXpmmb4zA77qrD6kG9lkzyMpu1TWrSCvXz-EGNO-MOiGAugcePf97Ly7LHFF5RysVrSKcuK87uZAtaFjQXVQ13swUUHPIGBD_JHsR4DUCLBur72QktK4CS0UX289KTtTGoRuINWbqd9SO6aF2-8u47htG6HVm7H3OP5Bwdko--m3sfhisbe-IdObMRZUz14HcBY7SpJp0mGzQj-YJuDFZNnQzkYh5SXPDD1UysI8tp9NH3siNnvrdOuvEmWs1xtIq8t9rh_Cf8YXbPyC7io8N9mn1-s_60usg3H87frpabXJW0GvNab5loGoVaCC2QV1pLZqSpNeVcNdhQkBU2VVGBlnKrmAEKRW1ACcWNVOw0e7HPHYL_NmEc295GhV0nHfoptjVlDeWs_C8saPrhqhQJPvsLXvspuDREWzCoBQfGEnq5Ryr4GAOadgi2l2FuKbS_F9zeLjjZp4fAadujPsrDRhN4fgAyKtmZIJ2y8eg4gxLq5tjZVxl2GG7B8t3lzUvtoE1CT_6J9r38Aj29xLc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230795033</pqid></control><display><type>article</type><title>No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease</title><source>MEDLINE</source><source>Karger Journals Complete</source><creator>Ecder, Tevfik ; McFann, Kimberly K. ; Raynolds, Mary V. ; Schrier, Robert W.</creator><creatorcontrib>Ecder, Tevfik ; McFann, Kimberly K. ; Raynolds, Mary V. ; Schrier, Robert W.</creatorcontrib><description>Background: Autosomal dominant polycystic kidney disease (ADPKD) shows a variable clinical course suggesting that genetic modifiers might play a role. There are conflicting results about the effect of angiotensin-converting enzyme (ACE) gene polymorphism on the progression of renal failure in ADPKD. Also, the association between ACE gene polymorphism and the occurrence of left ventricular hypertrophy (LVH) has not been investigated in patients with ADPKD. Methods: ACE genotype analysis was performed in 409 Caucasian patients (137 male, 272 female) with ADPKD. Echocardiographic examination was done in 164 of these patients. Results: There were no significant differences between different ACE genotypes regarding renal function, renal volume, urinary protein excretion, blood pressure, the rate of hypertension, the age at diagnosis of hypertension, the rate of LVH and the incidence of end-stage renal disease (ESRD). Conclusion: ACE gene polymorphism does not have a significant effect on the development of ESRD and the prevalence of LVH in patients with ADPKD.</description><identifier>ISSN: 0250-8095</identifier><identifier>EISSN: 1421-9670</identifier><identifier>DOI: 10.1159/000074653</identifier><identifier>PMID: 14600431</identifier><identifier>CODEN: AJNED9</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Adult ; Age of Onset ; Biological and medical sciences ; Blood Pressure - genetics ; Disease Progression ; European Continental Ancestry Group - genetics ; Female ; Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Humans ; Hypertrophy, Left Ventricular - epidemiology ; Hypertrophy, Left Ventricular - genetics ; Hypertrophy, Left Ventricular - physiopathology ; Kidney Failure, Chronic - epidemiology ; Kidney Failure, Chronic - genetics ; Kidney Failure, Chronic - physiopathology ; Kidney Function Tests ; Kidneys ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Original Report: Patient-Oriented, Translational Research ; Peptidyl-Dipeptidase A - genetics ; Polycystic Kidney, Autosomal Dominant - epidemiology ; Polycystic Kidney, Autosomal Dominant - genetics ; Polycystic Kidney, Autosomal Dominant - physiopathology ; Polymorphism, Genetic ; Tumors of the urinary system</subject><ispartof>American journal of nephrology, 2003-11, Vol.23 (6), p.466-470</ispartof><rights>2003 S. Karger AG, Basel</rights><rights>2004 INIST-CNRS</rights><rights>Copyright 2003 S. Karger AG, Basel</rights><rights>Copyright (c) 2003 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-7db3988ced99d9e56dda3faf7d155c8e810a6e86260daabc3f01027f0c9c5fac3</citedby><cites>FETCH-LOGICAL-c416t-7db3988ced99d9e56dda3faf7d155c8e810a6e86260daabc3f01027f0c9c5fac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15304078$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14600431$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ecder, Tevfik</creatorcontrib><creatorcontrib>McFann, Kimberly K.</creatorcontrib><creatorcontrib>Raynolds, Mary V.</creatorcontrib><creatorcontrib>Schrier, Robert W.</creatorcontrib><title>No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease</title><title>American journal of nephrology</title><addtitle>Am J Nephrol</addtitle><description>Background: Autosomal dominant polycystic kidney disease (ADPKD) shows a variable clinical course suggesting that genetic modifiers might play a role. There are conflicting results about the effect of angiotensin-converting enzyme (ACE) gene polymorphism on the progression of renal failure in ADPKD. Also, the association between ACE gene polymorphism and the occurrence of left ventricular hypertrophy (LVH) has not been investigated in patients with ADPKD. Methods: ACE genotype analysis was performed in 409 Caucasian patients (137 male, 272 female) with ADPKD. Echocardiographic examination was done in 164 of these patients. Results: There were no significant differences between different ACE genotypes regarding renal function, renal volume, urinary protein excretion, blood pressure, the rate of hypertension, the age at diagnosis of hypertension, the rate of LVH and the incidence of end-stage renal disease (ESRD). Conclusion: ACE gene polymorphism does not have a significant effect on the development of ESRD and the prevalence of LVH in patients with ADPKD.</description><subject>Adult</subject><subject>Age of Onset</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - genetics</subject><subject>Disease Progression</subject><subject>European Continental Ancestry Group - genetics</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Humans</subject><subject>Hypertrophy, Left Ventricular - epidemiology</subject><subject>Hypertrophy, Left Ventricular - genetics</subject><subject>Hypertrophy, Left Ventricular - physiopathology</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Failure, Chronic - genetics</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Function Tests</subject><subject>Kidneys</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Original Report: Patient-Oriented, Translational Research</subject><subject>Peptidyl-Dipeptidase A - genetics</subject><subject>Polycystic Kidney, Autosomal Dominant - epidemiology</subject><subject>Polycystic Kidney, Autosomal Dominant - genetics</subject><subject>Polycystic Kidney, Autosomal Dominant - physiopathology</subject><subject>Polymorphism, Genetic</subject><subject>Tumors of the urinary system</subject><issn>0250-8095</issn><issn>1421-9670</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0UGL1DAUB_AiijuuHjwLEgQFD9WXpmmb4zA77qrD6kG9lkzyMpu1TWrSCvXz-EGNO-MOiGAugcePf97Ly7LHFF5RysVrSKcuK87uZAtaFjQXVQ13swUUHPIGBD_JHsR4DUCLBur72QktK4CS0UX289KTtTGoRuINWbqd9SO6aF2-8u47htG6HVm7H3OP5Bwdko--m3sfhisbe-IdObMRZUz14HcBY7SpJp0mGzQj-YJuDFZNnQzkYh5SXPDD1UysI8tp9NH3siNnvrdOuvEmWs1xtIq8t9rh_Cf8YXbPyC7io8N9mn1-s_60usg3H87frpabXJW0GvNab5loGoVaCC2QV1pLZqSpNeVcNdhQkBU2VVGBlnKrmAEKRW1ACcWNVOw0e7HPHYL_NmEc295GhV0nHfoptjVlDeWs_C8saPrhqhQJPvsLXvspuDREWzCoBQfGEnq5Ryr4GAOadgi2l2FuKbS_F9zeLjjZp4fAadujPsrDRhN4fgAyKtmZIJ2y8eg4gxLq5tjZVxl2GG7B8t3lzUvtoE1CT_6J9r38Aj29xLc</recordid><startdate>200311</startdate><enddate>200311</enddate><creator>Ecder, Tevfik</creator><creator>McFann, Kimberly K.</creator><creator>Raynolds, Mary V.</creator><creator>Schrier, Robert W.</creator><general>Karger</general><general>S. Karger AG</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200311</creationdate><title>No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease</title><author>Ecder, Tevfik ; McFann, Kimberly K. ; Raynolds, Mary V. ; Schrier, Robert W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-7db3988ced99d9e56dda3faf7d155c8e810a6e86260daabc3f01027f0c9c5fac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - genetics</topic><topic>Disease Progression</topic><topic>European Continental Ancestry Group - genetics</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Humans</topic><topic>Hypertrophy, Left Ventricular - epidemiology</topic><topic>Hypertrophy, Left Ventricular - genetics</topic><topic>Hypertrophy, Left Ventricular - physiopathology</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Failure, Chronic - genetics</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Function Tests</topic><topic>Kidneys</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Original Report: Patient-Oriented, Translational Research</topic><topic>Peptidyl-Dipeptidase A - genetics</topic><topic>Polycystic Kidney, Autosomal Dominant - epidemiology</topic><topic>Polycystic Kidney, Autosomal Dominant - genetics</topic><topic>Polycystic Kidney, Autosomal Dominant - physiopathology</topic><topic>Polymorphism, Genetic</topic><topic>Tumors of the urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ecder, Tevfik</creatorcontrib><creatorcontrib>McFann, Kimberly K.</creatorcontrib><creatorcontrib>Raynolds, Mary V.</creatorcontrib><creatorcontrib>Schrier, Robert W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ecder, Tevfik</au><au>McFann, Kimberly K.</au><au>Raynolds, Mary V.</au><au>Schrier, Robert W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease</atitle><jtitle>American journal of nephrology</jtitle><addtitle>Am J Nephrol</addtitle><date>2003-11</date><risdate>2003</risdate><volume>23</volume><issue>6</issue><spage>466</spage><epage>470</epage><pages>466-470</pages><issn>0250-8095</issn><eissn>1421-9670</eissn><coden>AJNED9</coden><abstract>Background: Autosomal dominant polycystic kidney disease (ADPKD) shows a variable clinical course suggesting that genetic modifiers might play a role. There are conflicting results about the effect of angiotensin-converting enzyme (ACE) gene polymorphism on the progression of renal failure in ADPKD. Also, the association between ACE gene polymorphism and the occurrence of left ventricular hypertrophy (LVH) has not been investigated in patients with ADPKD. Methods: ACE genotype analysis was performed in 409 Caucasian patients (137 male, 272 female) with ADPKD. Echocardiographic examination was done in 164 of these patients. Results: There were no significant differences between different ACE genotypes regarding renal function, renal volume, urinary protein excretion, blood pressure, the rate of hypertension, the age at diagnosis of hypertension, the rate of LVH and the incidence of end-stage renal disease (ESRD). Conclusion: ACE gene polymorphism does not have a significant effect on the development of ESRD and the prevalence of LVH in patients with ADPKD.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>14600431</pmid><doi>10.1159/000074653</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0250-8095
ispartof American journal of nephrology, 2003-11, Vol.23 (6), p.466-470
issn 0250-8095
1421-9670
language eng
recordid cdi_pubmed_primary_14600431
source MEDLINE; Karger Journals Complete
subjects Adult
Age of Onset
Biological and medical sciences
Blood Pressure - genetics
Disease Progression
European Continental Ancestry Group - genetics
Female
Gene Frequency
Genetic Predisposition to Disease
Genotype
Humans
Hypertrophy, Left Ventricular - epidemiology
Hypertrophy, Left Ventricular - genetics
Hypertrophy, Left Ventricular - physiopathology
Kidney Failure, Chronic - epidemiology
Kidney Failure, Chronic - genetics
Kidney Failure, Chronic - physiopathology
Kidney Function Tests
Kidneys
Male
Medical sciences
Nephrology. Urinary tract diseases
Original Report: Patient-Oriented, Translational Research
Peptidyl-Dipeptidase A - genetics
Polycystic Kidney, Autosomal Dominant - epidemiology
Polycystic Kidney, Autosomal Dominant - genetics
Polycystic Kidney, Autosomal Dominant - physiopathology
Polymorphism, Genetic
Tumors of the urinary system
title No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A23%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20Effect%20of%20Angiotensin-Converting%20Enzyme%20Gene%20Polymorphism%20on%20Disease%20Progression%20and%20Left%20Ventricular%20Hypertrophy%20in%20Autosomal%20Dominant%20Polycystic%20Kidney%20Disease&rft.jtitle=American%20journal%20of%20nephrology&rft.au=Ecder,%20Tevfik&rft.date=2003-11&rft.volume=23&rft.issue=6&rft.spage=466&rft.epage=470&rft.pages=466-470&rft.issn=0250-8095&rft.eissn=1421-9670&rft.coden=AJNED9&rft_id=info:doi/10.1159/000074653&rft_dat=%3Cproquest_pubme%3E453405541%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230795033&rft_id=info:pmid/14600431&rfr_iscdi=true